Impact Investing Bond Health Innovation Campus Boxmeer I

PICTURE NECRON
Currency | CHF | EUR | USD |
Maturity in years | 2 |
Fix coupon | CHF 5.5% | EUR 6.5% | USD 7.25% |
Business Case
The Health Innovation Campus Boxmeer I is a forward-thinking center designed to drive innovation in healthcare and life sciences. Strategically located in the Dutch municipality of Boxmeer, the project comprises two key developments:
Marriott International Hotel, featuring two brands (Courtyard and Residence Inn) with a total of 416 rooms, catering to the growing demand for business and healthcare-related travel in the region.
Pantein Health Centre, a modern healthcare facility with a gross floor area of 13,800 m², which will become an integral part of the existing Maasziekenhuis Pantein hospital.
The project is being developed under the highest sustainability standards and will be BREEAM “Excellent” certified. As the first phase of the Health Innovation Campus Boxmeer, it is set to become a central hub for medical technology, healthcare institutions, and research facilities in the region.
Investment Opportunity
Qualified investors are invited to participate in the financing of Health Innovation Campus Boxmeer I. The bond offers:
- Coupon: CHF 5.5 % | EUR 6.5 % | USD 7.25 % p.a.
- Term: Maximum 24 months, with an early redemption option after 20 months
- Issuance Volume: 100 million CHF/EUR/USD
- Security: First-ranking mortgage, pledge of rental income, and sale proceeds
- This bond presents an attractive return opportunity with a stable income structure through long-term lease agreements with reputable tenants such as Marriott International and the Pantein Foundation.
Investment Benefits
✅ Sustainable Investment – BREEAM "Excellent"-certified project in a prime location
✅ High Security – First-ranking mortgage in favor of bondholders
✅ Long-term Lease Agreements – Fixed income with indexed rent and renowned tenants
✅ Attractive Yield – Fixed return with quarterly interest payments
✅ Significant Equity Contribution – 29.6% equity provided by the developer Necron
✅ Short Investment Term – Maximum term of 24 months with early redemption option
This investment allows qualified investors to participate in an innovative healthcare project with strong demand and sustainable value appreciation.
Product data
Product | Impact Investing Bond Health Innovation Campus |
Strategy | Boxmeer I |
Currency | CHF | EUR | USD |
Maturity in years | 2 |
Fix coupon | CHF 5.5% | EUR 6.5% | USD 7.25% |
ISIN | CHF: CH1423100937 / EUR: CH1423100929 / USD: CH1423100911 |
Valor | CHF: 142310093 / EUR: 142310092 / USD: 142310091 |
Bloomberg | CHF: ORBISS 5 ½ 04/11/27 / EUR: ORBISS 6 ½ 04/11/27 / USD: ORBISS 7 ¼ 04/11/27 |
Legal structure | Bearer bond secured by real estate lien (Senior Secured Bond) |
Security | Signed, long-term lease agreement |
Issue Size | CHF 100 M |
Issue date | 11 April 2025 |
Issue Price | CHF 1'000 |
Final maturity | 11 April 2027 |
Early Redemption Option | from 11 December 2026 with a 10 days’ notice |
Early Redemption Price | 100% plus accrued interest |
Denomination | Necron Group AG, Bahnhofstrasse 16, 6300 Zug, T. +41 41 561 38 22 |
Coupon Date | quarterly |
Offering for | qualified investors |
Paying Agent | Kaiser Partner Privatbank AG, Liechtenstein |
Subscription OTC | Kaiser Partner Privatbank AG, Herrengasse 23 | 9409 Vaduz | Liechtenstein Tel: +423 237 83 08 | E-Mail: rainer.nachbauer@kaiserpartner.com; elodie.hasler@kaiserpartner.com | |
Secondary market | Prices are regularly updated on Bloomberg, SIX Telekurs and Refinitiv (Reuters) (CH1356576582/CH1356539788/CH1357114284) Secondary market under normal market conditions, on a best-effort basis with 1.00% bid-offer |
Settlement | SIX SIS AG/Euroclear Bank S.A./N.V. Clearstream Banking S.A. |
Exchange | Vienna Stock Exchange |
Governing Law | Zürich 1, Schweiz |
ESG Rating | Sustainable project with BREEAM |
Your contacts


This content has been prepared by Picard Angst AG and is only a summary of the main features of the product and not a complete presentation and has been prepared solely for information purposes for use by the recipient for the duration of the subscription period. The information provided is valid only for this period. The information in this page does not constitute financial research and does not meet all legal requirements to ensure the impartiality of financial research and is not subject to any prohibition on trading prior to the publication of financial research. This page does not constitute an offer or invitation to buy or sell financial instruments. It is intended for informational purposes only. Given that an investment product can be a complex financial product, the decision to invest should therefore always be based on a consultation with a bank advisor. The information provided on this page on opportunities and risks is no substitute for the information provided by your investment advisor, which is always indispensable before concluding a transaction. Only those who are clear about the opportunities and risks of the transaction to be concluded and who are economically able to bear the losses that may occur should enter into such transactions.